Section of Infectious Diseases and Global Health
Assistant Professor of Medicine
Associate Hospital Epidemiologist and Associate Medical Director of Infection Control
Referring Physician Access Line: 1-877-DOM-2730
|BA||2003||Stanford University||Human Biology
|MD||2007||University of California San Francisco School of Medicine||
|Residency||2010||University of Chicago||Internal Medicine
|Fellowship||2012||University of Chicago||Infectious Diseases
|Fellowship||2013||University of Chicago||Healthcare Epidemiology
Dr. Ridgway's primary research focus is the impact of technology on healthcare epidemiology, particularly the use of informatics in infection control and prevention. She develops and studies syndromic surveillance algorithms using electronic health records. She also has a particular interest in the epidemiology of multidrug-resistant bacteria, including methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative organisms.
General infectious diseases;HIV/AIDS;Infections with Multidrug-resistant organisms;Bone and joint infections
- Ridgway J, Brown EC, Konchak C, Robicsek A. What’s Going Around?
The Use of Electronic Health Records to Perform Context-Specific Real-Time Syndromic Surveillance. IDWeek 2013. Poster Presentation. October 2013.
- Ridgway J, Peterson L, Thomson R, Miller B, Wright M, Robicsek A. Sensitivity of Multidrug-
Resistant Gram-Negative Organism Surveillance Testing in the Intensive Care Unit. IDWeek
2012. Poster Presentation. October 2012.
- Ridgway J, Peterson L, Brown EC, Du H, Hebert C, Thomson R, Kaul K, Robicsek A. Clinical Significance of Methicillin-Resistant Staphylococcus aureus Colonization on Hospital Admission: One-Year Infection Risk. PLOS ONE. In press.
- Hebert C, Ridgway J, Vekhter B, Brown E, Weber SG, Robicsek A. Demonstration of the
Weighted Incidence Syndromic Combination Antibiogram (WISCA): An Empiric Prescribing
Decision Aid. Infec Control Hosp Epidemiol. 2012 Apr; 33(4):381